Biobanking strategy and sample preprocessing for integrative
research in monoclonal gammopathies

J 2017

Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies

SEVCIKOVA, Tereza, Katerina GROWKOVA, Zuzana CHYRA, Jana FILIPOVA, P. VRUBLOVA et. al.

Basic information

Original name

Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies

Authors

SEVCIKOVA, Tereza (203 Czech Republic), Katerina GROWKOVA (203 Czech Republic), Zuzana CHYRA (203 Czech Republic, belonging to the institution), Jana FILIPOVA (203 Czech Republic), P. VRUBLOVA (203 Czech Republic), Tomas JELINEK (203 Czech Republic), Z. KORISTEK (203 Czech Republic), F. KRYUKOV (203 Czech Republic), Elena Vladimirovna KRYUKOVA (203 Czech Republic, guarantor, belonging to the institution) and Roman HÁJEK (203 Czech Republic)

Edition

Journal of clinical pathology, London, BMJ Publishing Group, 2017, 0021-9746

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30109 Pathology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Full Text

Impact factor

Impact factor: 2.894

RIV identification code

RIV/00216224:14110/17:00100122

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1136/jclinpath-2017-204329

UT WoS

000411180200006

Keywords in English

monoclonal gammopathies; MULTIPLE-MYELOMA; BONE-MARROW; PLASMA-CELLS; CRITERIA; DISEASE; RNA

Abstract

V originále

Aims Some types of monoclonal gammopathies are typified by a very limited availability of aberrant cells. Modern research use high throughput technologies and an integrated approach for detailed characterisation of abnormal cells. This strategy requires relatively high amounts of starting material which cannot be obtained from every diagnosis without causing inconvenience to the patient. The aim of this methodological paper is to reflect our long experience with laboratory work and describe the best protocols for sample collection, sorting and further preprocessing in terms of the available number of cells and intended downstream application in monoclonal gammopathies research. Potential pitfalls are also discussed. Methods Comparison and optimisation of freezing and sorting protocols for plasma cells in monoclonal gammopathies, followed by testing of various nucleic acid isolation and amplification techniques to establish a guideline for sample processing in haemato-oncology research. Results We show the average numbers of aberrant cells that can be obtained from various monoclonal gammopathies (monoclonal gammopathy of undetermined significance/light chain amyloidosis/multiple myeloma (MM)/MM circulating plasma cells/minimal residual disease MM-10 123/22 846/305 501/68 641/4000 aberrant plasma cells of 48/30/10/16/37x106 bone marrow mononuclear cells) and the expected yield of nucleic acids provided from multiple isolation kits (DNA/RNA yield from 1 to 200x10(3) cells was 2.14-427/0.12-123 ng). Conclusions Tested kits for parallel isolation deliver outputs comparable with kits specialised for just one type of molecule. We also present our positive experience with the whole genome amplification method, which can serve as a very powerful tool to gain complex information from a very small cell population.

Citovat

SEVCIKOVA, Tereza, Katerina GROWKOVA, Zuzana CHYRA, Jana FILIPOVA, P. VRUBLOVA, Tomas JELINEK, Z. KORISTEK, F. KRYUKOV, Elena Vladimirovna KRYUKOVA and Roman HÁJEK. Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies. Journal of clinical pathology. London: BMJ Publishing Group, 2017, vol. 70, No 10, p. 847-853. ISSN 0021-9746. Available from: https://dx.doi.org/10.1136/jclinpath-2017-204329.

@article{1409448,
   author = {Sevcikova, Tereza and Growkova, Katerina and Chyra, Zuzana and Filipova, Jana and Vrublova, P. and Jelinek, Tomas and Koristek, Z. and Kryukov, F. and Kryukova, Elena Vladimirovna and Hájek, Roman},
   article_location = {London},
   article_number = {10},
   doi = {http://dx.doi.org/10.1136/jclinpath-2017-204329},
   keywords = {monoclonal gammopathies; MULTIPLE-MYELOMA; BONE-MARROW; PLASMA-CELLS; CRITERIA; DISEASE; RNA},
   language = {eng},
   issn = {0021-9746},
   journal = {Journal of clinical pathology},
   note = {Doplnit podíly spolupracovišť!},
   title = {Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749344/pdf/jclinpath-2017-204329.pdf},
   volume = {70},
   year = {2017}
}

TY  - JOUR
ID  - 1409448
AU  - Sevcikova, Tereza - Growkova, Katerina - Chyra, Zuzana - Filipova, Jana - Vrublova, P. - Jelinek, Tomas - Koristek, Z. - Kryukov, F. - Kryukova, Elena Vladimirovna - Hájek, Roman
PY  - 2017
TI  - Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies
JF  - Journal of clinical pathology
VL  - 70
IS  - 10
SP  - 847-853
EP  - 847-853
PB  - BMJ Publishing Group
SN  - 00219746
N1  - Doplnit podíly spolupracovišť!
KW  - monoclonal gammopathies
KW  - MULTIPLE-MYELOMA
KW  - BONE-MARROW
KW  - PLASMA-CELLS
KW  - CRITERIA
KW  - DISEASE
KW  - RNA
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749344/pdf/jclinpath-2017-204329.pdf
L2  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749344/pdf/jclinpath-2017-204329.pdf
N2  - Aims Some types of monoclonal gammopathies are typified by a very limited availability of aberrant cells. Modern research use high throughput technologies and an integrated approach for detailed characterisation of abnormal cells. This strategy requires relatively high amounts of starting material which cannot be obtained from every diagnosis without causing inconvenience to the patient. The aim of this methodological paper is to reflect our long experience with laboratory work and describe the best protocols for sample collection, sorting and further preprocessing in terms of the available number of cells and intended downstream application in monoclonal gammopathies research. Potential pitfalls are also discussed. Methods Comparison and optimisation of freezing and sorting protocols for plasma cells in monoclonal gammopathies, followed by testing of various nucleic acid isolation and amplification techniques to establish a guideline for sample processing in haemato-oncology research. Results We show the average numbers of aberrant cells that can be obtained from various monoclonal gammopathies (monoclonal gammopathy of undetermined significance/light chain amyloidosis/multiple myeloma (MM)/MM circulating plasma cells/minimal residual disease MM-10 123/22 846/305 501/68 641/4000 aberrant plasma cells of 48/30/10/16/37x106 bone marrow mononuclear cells) and the expected yield of nucleic acids provided from multiple isolation kits (DNA/RNA yield from 1 to 200x10(3) cells was 2.14-427/0.12-123 ng). Conclusions Tested kits for parallel isolation deliver outputs comparable with kits specialised for just one type of molecule. We also present our positive experience with the whole genome amplification method, which can serve as a very powerful tool to gain complex information from a very small cell population.
ER  -

SEVCIKOVA, Tereza, Katerina GROWKOVA, Zuzana CHYRA, Jana FILIPOVA, P. VRUBLOVA, Tomas JELINEK, Z. KORISTEK, F. KRYUKOV, Elena Vladimirovna KRYUKOVA and Roman HÁJEK. Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies. \textit{Journal of clinical pathology}. London: BMJ Publishing Group, 2017, vol.~70, No~10, p.~847-853. ISSN~0021-9746. Available from: https://dx.doi.org/10.1136/jclinpath-2017-204329.

Detailed Information on Publication Record